Related News
Survival rate of patients with most common type of lung cancer has doubled in 10 years
Online Edition
The survival rate of patients with the most common type of lung cancer more than doubled in the past 10 years, when targeted medicine became available on the Chinese market, experts said a medical forum today.
Non-small-cell lung cancer accounts for 80 percent of all lung cancer cases and 75 percent of patients with such cancer are diagnosed at the terminal stage.
Targeted medicine attacks cancerous tissue with little damage to healthy cells, thus greatly reducing side effects.
The average length of survival has been prolonged from 14.1 months to 33.5 months and the five-year survival rate, which considered as recovery clinically, has increased from 8 percent to 18 percent.
Lung cancer is the most common cancer in China and the country’s biggest cancer killer.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
